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undergo PCI within 90 minutes of FMC, should be treated with 
fibrinolytic therapy within 30 minutes of hospital presentation, 
unless such therapy is contraindicated.
A recent study in STEMI patients found that while p-PCI was 
performed in 60%, the majority of the interventions occurred 
later than 120 minutes, and that only 36% received fibri-
nolysis.(2) This high percentage of patients receiving angiography 
and an invasive treatment strategy may be explained by the 
location of the participating centers in urban areas, almost all of 
which were private healthcare facilities.
Early and appropriate pre-hospital diagnosis, as well as 
immediate transport, are of vital importance to avoid unnec-
ABSTRACT
The SA Heart Association seeks to to improve the early 
management of ST-segment elevation myocardial 
infarction in South Africa.  This pilot study was under-
taken to establish the current time intervals present 
in the referral pathways to percutaneous coronary 
intervention (PCI) facilities in the Tshwane Metropole 
and to further identify the barriers to appropriate 
management of STEMI.  
Method: Cardiologists from 5 PCI-capable hospitals 
recruited the patients in the catheterisation laboratory 
and captured the data.  Interviews were conducted with 
three emergency medical services (EMS) to assess 
paramedics’ scope of practice and identify hindrances 
to the effective management of STEMI patients.   
Results:  Median system delays were longer in patients 
requiring inter-facility transport (IFT; n=29) compared 
to patients with direct access to a PCI facility (DA) 
patients (median 3.7 vs. 30.4 hours; p<0.001).  Door-to-
balloon times of ≤90 minutes were achieved in only 22% 
DA and 33% IFT patients. Fibrinolysis within ≤30 
minutes was achieved in 50% DA and 20% IFT patients. 
Reperfusion was attempted in <12 hours of symptom 
onset in signifi cantly more DA than IFT patients (70% 
vs. 34%; p=0.012 respectively).  Paramedics were suitably 
trained and ambulances reasonably equipped to manage 
STEMI patients. However, members of the public do not 
routinely summon EMS. 
Conclusion:  Education initiatives and improved systems 
of care have the potential to improve STEMI patient 
outcome in South-Africa.  SAHeart 2015;12:74-80
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South African cardiologists frequently encounter patients with 
ST-segment elevation myocardial infarction (STEMI). Not 
infrequently, patients present for medical care long after the 
onset of symptoms and without having received any prior 
reperfusion therapy. There is no standardised management 
protocol for the management of STEMI in the public or private 
sector. The key objectives of the SA Heart STEMI Early 
Reperfusion Project are to improve quality of acute myocar-
dial infarction (AMI) care and to improve the care network to 
ensure prompt access to reperfusion therapy and decrease 
mortality from AMI. 
These objectives accord with the European Society of 
Cardiology’s (ESC) Stent for Life programme to promote the 
implementation of their guidelines in the management of AMI 
and to identify the specific barriers to their implementation. A 
further objective is to formulate key actions to ensure that the 
majority of STEMI patients have access to primary percutaneous 
coronary intervention (p-PCI) within 120 minutes.(1) According 
to the ESC guidelines,(1) it is a CLASS 1 A recommendation that 
STEMI patients presenting to a hospital with PCI capability 
should be treated with primary PCI within 90 minutes of first 
medical contact (FMC), while it is a CLASS 1 B recommendation 
that STEMI patients presenting to a hospital without PCI 
capability, and who cannot be transferred to a PCI center and 


















essary case fatalities.(3,4) Ideally patients should have access to a 
referral pathway to p-PCI that is managed by informed 
professionals and is free of delays and bottlenecks. Patient, 
system and other delays contribute to the inability to meet 
quality targets.(4-6) Factors contributing to extended referral 
pathways, such as cath lab activation times and door-to-balloon 
time, need to be identified and specifically targeted to ensure 
improved patient outcomes.  
The SA Heart Association performed this pilot survey to 
investigate which factors contribute to ineffective management 
of STEMI patients admitted by cardiologists in the Tshwane 
metropolitan area by determining time lapses along the referral 
pathway associated with direct admissions and secondary 
referrals to cath labs and by assessing type and timeliness of 
treatment. The Tshwane metropolitan area was deemed 
suitable for the pilot study for reasons of convenience. The 
total population of the City of Tshwane is approximately 2.9 
million within an area of 6 368km2, extending approximately 
121km from west to east and 108km from north to south. The 
purpose of the survey was to inform the design and imple-
mentation of education initiatives to be directed at all key 
players aiming to improve patient access to p-PCI. Some of the 
findings of the pilot survey have already been described in a 
report on STEMI systems of care in emerging countries.(7) A 
more detailed report on the survey findings is presented here, 
as well as an algorithm for treatment intervention and the 
project plan for the SA Heart STEMI Early Intervention Project 
for South Africa.
METHODS
A cross-sectional observational study was performed, employing 
convenience sampling, from May to October 2012 in 5 cath lab 
hospitals in Pretoria. Data for consecutive STEMI patients from 
Tshwane and surrounding areas (including 18 referring urban 
private hospitals in the North West, Mpumalanga and Limpopo 
provinces) were collected in private cath labs in Pretoria by 
the treating cardiologist. Common referral pathways were 
established, time intervals along the pathway were determined 
and type and timeliness of treatment was investigated. 
Administration of fibrinolytics was recorded pre- and post-
admission to the PCI facility.
Twenty-nine inter-facility transfer (IFT) (from a non-PCI-
capable hospital to a PCI-capable hospital) and 23 direct access 
to a PCI-capable hospital (DA) patients were included in the 
study following exclusion of three NSTEMI patients. Patients 
were classified as IFT or DA, irrespective of FMC prior to 
admission to a hospital. One patient could not be admitted to 
a PCI facility due to a lack of funds. Five patients with missing 
data on more than one time point were excluded. Data 
regarding the onset of symptoms was not available for one DA 
and five IFT patients, and time of admission to cath lab was not 
reported for two DA patients. Patient history data was not 
reported for three DA and two IFT patients. First medical 
contact to diagnosis time was reported as zero minutes in six 
DA and three IFT patients. Fibrinolytic therapy was only 
recorded for 21 IFT and 22 DA patients.
Emergency Medical Services (EMS) in the City Of Tshwane 
comprise one public- and 24 private providers. Interviews were 
conducted with personnel from the three major EMS providers 
who are capable of appropriate transport and care for myo-
cardial infarction patients (Netcare 911, ER24 and Europ 
Assistance) to assess their scope of practice and also to identify 
what they perceived as barriers to effective management of 
STEMI patients.  
Statistical analyses were performed employing STATISIX 9, 
2008 Analytical software (Tallahassee FL, USA). Between-
group comparisons were performed with the Wilcoxon sign 
rank tests for continuous variables and the chi-square test for 
dichotomised variables. Logistic regression analyses were 
performed to identify factors contributing to treatment delay 
beyond defined treatment goals. 
RESULTS
Ten patients were attended to by a physician prior to admission, 
five of whom were DA cases and five IFT cases. Two IFT 
patients died during PCI, one female and one male. Only one 
patient used EMS for transport to the hospital. This patient 
lived alone and first called her family, who in turn called an 
ambulance on her behalf. All others used their own transport 
(usually a family member’s car) to bring them to the hospital.  
Time delays associated with the process, from symptom onset 
to cath lab admission, and distribution of patients across referral 
routes are depicted in Figure 1. Five IFT and five DA patients, 
whose FMC was a general practitioner, came from remote 
areas.  The other patients resided in the City of Tshwane and 
went directly to a non-PCI (n=24) or a PCI facility (n=18). 
The 24 IFT patients, whose FMC was an emergency physician 
at a non-PIC facility, were referred to a PCI-capable hospital 
for further treatment. The risk profiles of the referral pathway 
groups were similar although patients previously diagnosed 
with myocardial ischaemic events appeared more likely to 
follow the direct access route (Table 1).  
Significant patient delays (delay between symptom onset and 
FMC) were evident in both referral groups (Table 2) but did 
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not differ significantly between referral groups. Excessive system 
delays (delay between FMC and admission to cath lab) were 
also observed in both groups, with significantly longer delays for 
IFT patients compared to DA patients. FMC did not occur 
within 120 minutes in 45% and 68% of DA and IFT patients 
respectively. The treatment goal of performing p-PCI in ≤60 
and 90 minutes from FMC was achieved only in DA patients in 
13% and 22% respectively. 
Ninety-six percent of DA patients and 72% of IFT patients had 
received fibrinolytics (Table 3) and although the 2 groups did 
not differ significantly with regards to the time lapse between 
FMC and administration of fibrinolytics, the treatment goal of 
administering fibrinolytics in ≤30 minutes from FMC was only 
achieved in 50% of DA and 20% of IFT patients (Table 2). 
Table 3 presents information on the different types of fibri-
nolytics that were administered pre-and post-admission to a 
PCI-capable hospital. 
Reperfusion delays of more than 12 hours from symptom 
onset were explained by patients delays (duration to FMC 
dichotomised as ≤/>120 minutes of symptom onset) (Odds 
ratio 16.5; 95% CI 3.0-91.8), independent of referral pathway 
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*Reported as median (range).
TABLE 2: Time intervals from onset of symptoms 
to reperfusion 
Symptom onset to FMC
FMC to cath lab admission
FMC within 120 minutes 
of symptom onset
FMC to Primary PCI 
≤90 minutes 
Or
 ≤60 minutes  in patients 
presenting within 120 
minutes of symptom onset 
or at a PCI-capable facility




FMC to fi brinolysis time*
FMC to fi brinolysis 
≤30 minutes
Total time delay to 
reperfusion therapy by PCI
Reperfusion in all patients 




























(34 - 2 017)
1 822 












 (46 - 4 628) 
4/21 (20%)
3 363


















Time intervals are reported as minutes: Median (IQ range). FMC: First medical contact,
χ2: Chi square test, *Direct access (n=22) and Inter-facility transfer (n=21).
FIGURE 1:  Distribution of patients across referral 
routes and time delays from onset of symptoms to 
cath lab admission associated with referral route
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and system delays dichotomised as ≤/>90 minutes of FMC. 
Risk for fibrinolysis being delayed more than 30 minutes 
after FMC increased four-fold with IFT (Odds ratio 95% CI: 
1.01-15.86).
The key findings of the interviews with EMS providers were as 
follows:
 ■ Ambulances are equipped with a 3-lead ECG only.
 ■ When a patient calls in complaining of chest pain, a response 
vehicle is simultaneously dispatched by some emergency 
service providers. The response vehicle is manned by more 
highly qualified staff and has a 12-lead ECG. 
 ■ Some ambulances/response vehicles have the capability to 
transmit an ECG via cell phone to an e-mail address. This 
equipment costs R180 000. Others rely on the paramedic 
taking a photograph of the ECG and sending it to another 
phone.
 ■ There have been instances in which, although the patient 
was delivered to a PCI-capable facility, transfer to another 
facility was mandated by the patient’s insurer, resulting in 
needless delays.
DISCUSSION
In broad terms, this small observational study provides the 
outline on which a national survey can be planned. Significant 
patient and system delays were evident in both referral groups, 
and in particular in the IFT group (Table 2, Figure 1), with the 
excessive system delays compounding the risk in a significant 
number of patients whose FMC was beyond 120 minutes of 
symptom onset. Time lapses between FMC /non-PCI-capable 
hospitals and PCI-capable hospitals were unnecessarily long and 
partially explain why 30% of DA and 65% of IFT patients failed 
to receive timely reperfusion. Patient reaction times suggest 
that they were uninformed regarding possible symptoms, the 
importance of timely treatment and the importance of being 
treated in a PCI-capable hospital. Upon analysis of the South 
Africa Heart Association registry data, Shamroth, et al.(2) 
reported median (IQ range) time intervals of 3.6 (1.6; 9.5) 
hours between the onset of symptoms and arrival at a hospital 
in a population in which 64% of patients lived within a 30-minute 
drive from the admitting hospital. The longer time intervals 
reported in our study may reflect the longer distances patients 
need to travel from referral hospitals to PCI-capable facilities. 
Although the pharmaco-invasive strategy is advocated for 
STEMI patients living in remote areas with no ready access to 
PCI facilities, only 65% of IFT patients received a fibrinolytic 
agent and treatment was delayed until admission to a PCI facility 
in four of the 23 patients. In addition, fibrinolysis was performed 
at a median time of four hours and 34 minutes (range 00:02-
09:09 hrs:min), well beyond the recommended limit of ≤30 
minutes.(1)  Difficulty in diagnosing STEMI in IFT patients has 
been reported previously and has been ascribed to symp-
toms and early ECG changes being less clear in this cohort 
of patients.(6) The authors suggest that “initial triage to a 
non-primary PCI center may be justifiable due to diagnostic 
uncertainty, and that guideline time metrics should be amended 
appropriately”.(6) However, IFT due to misdiagnosis is asso-
ciated with significantly higher 1-year mortality.(8) 
A recent retrospective study in Cape Town (2008 - 2010) 
reported a median “door-to-needle” time of 54 minutes (range 
13 - 553 minutes).(9) A fibrinolytic agent was administered 
in only 44.7% of cases despite 88.8% typical symptoms of 
myocardial infarction. A “door-to-needle” time of 30 minutes 
or less was achieved in 33 (20.5%) patients; 51.3% of these 
patients arrived by ambulance; 34% had a pre-hospital 12-lead 
ECG. These deviations from recommended practice were 
ascribed to a lack of senior doctors, difficulty interpreting 
ECGs, atypical presentations and delays in emergency centers. 
Of note, 51.3% of the patients enrolled for this study were 
transported by ambulance and a 12-lead ECG was performed 
pre-hospital in 34% of patients.(9) 
“Time to treatment” and “door-to-balloon” time are both 
significant determinants of mortality in STEMI.(4) Total time 
delays to reperfusion therapy by PCI of approximately eight 
hours for DA patients and 56 hours for IFT patients were 
observed in this study, and “door-to-balloon” time of ≤90 
minutes was only achieved in 22% of DA and 33% of IFT 
patients. Of concern is that only 22% of DA and none of 
TABLE 3: Fibrinolytic treatment administered post- 





























Pre-arrival treatment numbers reported in brackets.
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the IFT patients received p-PCI within 90 minutes of FMC. 
System delays with DA need to be scrutinised in particular in 
national follow-up studies for targeted intervention to opti-
mise outcome in this referral group. 
Findings relating to Emergency Medical Service 
(EMS) provision
The scope of practice of emergency care providers for the 
different levels of training is as follows:(10)
 ■ A Basic Ambulance Assistant (BAA) provides basic life 
support and is able to administer oxygen and interpret vital 
signs. They do not have access to any medication, nor may 
they administer drugs. They are unable to attach or interpret 
an ECG.
 ■ Ambulance Emergency Assistants (AEA) and Emergency 
Care Technicians are qualified to provide intermediate life 
support. They may set up an intravenous infusion, administer 
aspirin and attach and interpret a 3-lead ECG (to recognise 
ST elevation or depression and interpret critical cardiac 
arrhythmias).
 ■ The Critical Care Assistant (CCA) provides advanced life 
support. They are licensed to administer nitrates and 
morphine. Some may be able to attach, perform and 
interpret a 12-lead ECG.
 ■ Emergency Care Practitioners (Bachelors Degree in Tech-
nology or Bachelors Degree in Emergency Medical Care) 
are qualified to administer thrombolytic therapy. 
Four of the 5 qualifications for emergency care providers 
include interpretation of an ECG within their scope of practice, 
which implies that EMS personnel are well equipped to 
recognise and manage STEMI patients appropriately while 
those with a Bachelors Degree in Technology or in Emergency 
Medical Care are qualified to administer fibrinolytic treatment. 
Ambulances are equipped with a 3-lead ECG only, while 
response vehicles have 12-lead ECG machines on board. 
Solutions need to be found for the immediate transmission 
of the ECG to a control center for early diagnosis and 
appropriate referral of the patient. All paramedics should be 
adequately trained to make the “time-sensitive” diagnosis of 
STEMI and triage the patients successfully as this has the 
potential to have major impact on patient outcome.(11) Ideally 
EMS should be mandated to promptly activate the cath lab 
team.(12) The finding that EMS is not routinely solicited by the 
public prompts urgent implementation of public awareness 
initiatives. 
FUTURE STRATEGIES
Strategy to establish functional regions
The goals to be attained within the next 24 months are defined 
as follows:
 ■ Recruiting a key cardiologist in each region to drive the 
project.
 ■ Establishment of contact with all relevant stakeholders to 
inform them of what the project entails and to solicit their 
collaboration.
 ■ Commencement of the Early Reperfusion Project training, 
once buy-in has been obtained, in the following sequence:
–   Hospitals with a cath lab (involving personnel in intensive 
care units, emergency department, hospital manager, 
nursing manager);
–   Hospitals without cath labs (involving personnel in 
emergency rooms from all city hospitals and other 
referring suburban centers, and also referring GP 
practices); and
–   EMS personnel.
 ■ Launching of a patient awareness programme through the 
Heart and Stroke Foundation (HSF) within the broader 
context of acute coronary syndrome management. 
 ■ Establishment of a network amongst STEMI care providers, 
central and local government, medical insurance companies, 
private sector funders. 
 ■ Establishment of a registry with meticulous data collection 
and follow up to ensure the collection of reliable outcome 
data. A study protocol has been developed to establish the 
effectiveness of the education and networking initiatives 
and to identify remaining constraints, unmet training needs 
and organisational shortfalls across other regions. The 
objective of the proposed study is to inform the compila-
tion of South African STEMI treatment guidelines and to 
define standards against which the systems of care are 
monitored. 
The patient awareness programme needs to be prioritised, 
based on the finding of this pilot study that risk for missing the 
treatment goal for reperfusion <12 hours duration of symptom 
onset increases seventeen-fold if duration to FMC exceeds 120 
minutes of symptom onset, independent of referral pathway. 
Following this strategy it is hoped that concerted action amongst 
the role players will ensure early reperfusion by appropriate 
intervention and that the DA strategy will be followed when-
ever possible. 


















STEMI management algorithm 
This simple algorithm has been developed to facilitate effective 
STEMI management (Figure 2).
In essence, time to treatment is critical during the first two to 
three hours after symptom onset. Therefore, anti-platelet 
therapy and immediate p-PCI is favoured within the first two 
hours following onset of pain. After 3 hours p-PCI is preferred 
if it can be performed within 2 hours of FMC. If this is not 
possible, an immediate pharmacoinvasive strategy with fibri-
nolysis followed by transfer for PCI within the next 3 to 24 
hours is recommended because late reperfusion may improve 
myocardial salvage and survival. Immediate or “rescue” PCI 
should be performed for failed reperfusion after fibrinolysis.
Lack of first-line treatment of STEMI with Aspirin is of specific 
concern, especially with inter-facility transfer of patients, as is 
evident from this pilot study (Table 3), and needs to be 
addressed. Furthermore, the choice of fibrinolytic agent is 
important to ensure effective reperfusion and there is a need 
to replace streptokinase in the public sector with a fibrin-
specific agent.
Additional considerations
No single practitioner working in isolation can alter outcomes, 
as evidenced by results from abroad.(7) We hope to establish an 
effective network between the various stakeholders and create 
a fully functional central hub that oversees all initiatives and 
monitors progress through the maintenance of a registry. The 
mismatch between need and availability of PCI-capable facilities 
remains a concern(7) but success stories relating to government 
involvement in other countries are encouraging.(7,13,14) 
Perceived South African healthcare challenges (personal obser-
vations) that need to be considered relate to: 
 ■ Public/private sector mismatch: 70% of South African 
patients in the public (government) sector being cared for 
by 30% of doctors, and 30% percent of South African 
patients being treated by private cardiologists; 
 ■ Shortage of cardiologists: 4 out of 11 provinces not having 
one registered cardiologist; 
 ■ Treatment constraints: 20% of private patients having 
varying levels of medical insurance;
 ■ Collaboration amongst cardiologists: Cardiologists tend to 
work as individuals and not as a team in hospitals that 
belong to 1 of the 4 major private groups; and
 ■ National fiscal constraints: South Africa implementing 
National Health Insurance (NHI) while currently struggling 
to deliver healthcare.
Limited human resources and financial constraints may affect 
the establishment of an effective STEMI system of care. 
Although private cardiologists assist with the training of 
cardiologists and with patient care in the public sector, it is 
questionable whether closer cooperation between these 
sectors is possible because of regulatory and logistic constraints. 
Involvement of private funders may alleviate some of the 
financial burdens of the project and will contribute to successful 
STEMI management in South Africa, but key to the success of 
the project probably lies an individual commitment towards 
education of all parties involved and encouraging collaboration 
within regions. Although the primary focus of the project is the 
management of STEMI patients, all acute coronary syndrome 
(ACS) patients are expected to benefit from the intervention. 
Strategies to establish functional regions have been identified 
and the follow-up national study investigating the causes of 
delay in early reperfusion in STEMI patients in South Africa has 
commenced. Although the challenges appear daunting, the 
FIGURE 2:  Simplifi ed algorithm for STEMI 
management




Immediate PCI (if <120min)
Ship* immediately to closest 
cath lab (if <120min)
Closest cath lab
Drip** and then ship to closest 





lessons learnt from other countries are encouraging(7) and 
much may be learnt from their experiences in treating patients 
coming from remote areas.(15,16)
LIMITATIONS
The limitations of this pilot study relate to the small sample size 
and the incompleteness of the data. A true reflection of the 
distribution of cases, in accordance with treatment guidelines 
across the different referral pathways, is lacking. Ideally a 
distinction should be made between p-PCI, coronary angio-
graphy with follow-on PCI in patients presenting >12 hours of 
the onset of symptoms, coronary angiography with follow-on 
rescue PCI within 60 - 90 minutes after administration of 
fibrinolytics in patients with failed reperfusion, and coronary 
angiography with follow-on rescue PCI in patients with recur-
rent myocardial ischemia after fibrinolysis. The timeliness of all 
types of PCI interventions, as defined above, is worthy of 
consideration in the national survey to follow. 
CONCLUSION
This pilot study demonstrates that there are a number of 
barriers to the effective treatment of STEMI patients in South 
Africa. Fostering collaboration between all role players and 
encouraging concerted action in the various regions in managing 
these patients should ensure that better outcomes are achieved, 
not only for them, but for all patients with an acute coronary 
syndrome.
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